# Recombinant Follicle-stimulating Hormone in Treatment for Infertility

> **NCT05266924** · PHASE3 · UNKNOWN · sponsor: **Bharat Serums and Vaccines Limited** · enrollment: 250 (estimated)

## Conditions studied

- Female Infertility

## Interventions

- **DRUG:** Recombinant Human Follicle Stimulating Hormone 900 IU (66.0 μg) / 1.5mL Solution for Injection in Prefilled Pen

## Key facts

- **NCT ID:** NCT05266924
- **Lead sponsor:** Bharat Serums and Vaccines Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-23
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-11-30
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05266924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05266924, "Recombinant Follicle-stimulating Hormone in Treatment for Infertility". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05266924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*